Determinants of amikacin first peak concentration in critically ill patients-Reference-Cited by-同舟云学术

Determinants of amikacin first peak concentration in critically ill patients

Published:2018-05-23 Issue:6 Volume:32 Page:669-677
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Boidin Clément¹²^ORCID,Jenck Sophie³,Bourguignon Laurent¹²⁴,Torkmani Sejad³,Roussey-Jean Aurore³,Ledochowski Stanislas³,Marry Lucie⁵,Ammenouche Nacim⁵,Dupont Hervé⁵,Marçon Frédéric⁶,Allaouchiche Bernard³⁷,Bohé Julien³⁷,Lepape Alain³⁸,Goutelle Sylvain¹²⁴,Friggeri Arnaud³⁷⁸

Affiliation:

1. Groupement Hospitalier Nord; Service de Pharmacie; Hôpital Pierre Garraud; Hospices Civils de Lyon; 136 rue du Commandant Charcot 69322 LyonCedex 5 France

2. Laboratoire de Biométrie et Biologie Évolutive; Université Claude Bernard Lyon 1; UMR CNRS 5558; University of Lyon; Bât. Grégor Mendel, 43 bd du 11 novembre 1918 69622 Villeurbanne Cedex France

3. Groupement Hospitalier Sud; Service d'Anesthésie et de Réanimation; Hospices Civils de Lyon; 165 Chemin du Grand Revoyet 69495 Pierre-Bénite France

4. ISPB - Faculté de Pharmacie de Lyon; Université Claude Bernard Lyon 1; University of Lyon; 8 Avenue Rockefeller 69003 Lyon France

5. Service d'Anesthésie et de Réanimation; Centre Hospitalier Universitaire Amiens-Picardie; Site Sud 80054 Amiens Cedex 1 France

6. Service de Pharmacie; Centre Hospitalier Universitaire Amiens-Picardie; Site Sud 80054 Amiens Cedex 1 France

7. Faculté de Médecine Lyon Sud-Charles Mérieux; Université Claude Bernard Lyon 1; University of Lyon; 165 Rue du Petit Revoyet 69600 Oullins France

8. Laboratoire des Pathogènes Émergents; Université Claude Bernard Lyon 1; UMR CNRS 5308; Inserm U1111; Centre International de Recherche en Infectiologie; University of Lyon; 21 avenue Tony Garnier 69365 Lyon cedex 07 France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12374/fullpdf

Reference43 articles.

1. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides;Deziel-Evans;Clin. Pharm.,1986

2. Experience with a once-daily dosing program of aminoglycosides in critically ill patients;Buijk;Intensive Care Med.,2002

3. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients;Nicolau;Antimicrob. Agents Chemother.,1995

4. Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro;Karlowsky;J. Antimicrob. Chemother.,1994

5. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016;Rhodes;Crit. Care Med.,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amikacin in emergency surgery: How to dose it optimally?;Anaesthesia Critical Care & Pain Medicine;2022-02

2. Simultaneously Determining Seven Second-Line Anti-TB Drugs by UHPLC-MS: Application for TDM in HIV-TB Patients;Current Pharmaceutical Analysis;2021-11-23

3. An international survey on aminoglycoside practices in critically ill patients: the AMINO III study;Annals of Intensive Care;2021-03-19

4. Evaluation of Current Amikacin Dosing Recommendations and Development of an Interactive Nomogram: The Role of Albumin;Pharmaceutics;2021-02-15

5. Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database;Annals of Intensive Care;2020-06-08